SLE and pediatric rheumatology Archives

Abstract Number: 1385 • ACR/ARHP Annual Meeting 2016
Frequency of the Systemic Lupus Collaborating Clinics- Damage Index Items in Three Registries of Childhood-Onset Systemic Lupus Erythematosus
Michael J. Holland¹, Michael W. Beresford^2,3,4, Nicolino Ruperto⁵, Allen Watts¹, Kasha Wiley¹, Elisabetta Cortis^5,6, Seza Ozen^5,7, Oscar Porras^5,8, Flavio Sztajnbok^5,9, Maria Apaz^5,10 and Hermine I. Brunner¹, ¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, United Kingdom, ³Alder Hey Children's NHS Foundation Trust Hospital, Institute of Translational Medicine (Child Health), University of Liverpool, Liverpool, United Kingdom, ⁴On Behalf of the UK JSLE Study Group, Liverpool, United Kingdom, ⁵Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genoa, Italy, ⁶Santa Maria della Stella Hospital, Orvieto, Italy, ⁷Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ⁸Hospital Nacional de Niños, San Jose, Costa Rica, ⁹Pediatric Rheumatology Division, Adolescent Health Care Unit, Universida de do Estado do Rio de Janeiro., Rio de Janeiro, Brazil, ¹⁰Pediatric Rheumatology, Hospital de Niños de Cordoba, Córdoba, Argentina
Background/Purpose: Childhood-Onset Systemic Lupus Erythematosus (cSLE) is a chronic, multi-system autoimmune disease. In addition to active inflammation, cSLE may result in irreversible damage to affected…
Abstract Number: 1312 • ACR/ARHP Annual Meeting 2014
Features, Treatment and Outcome of Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus
Roberto Ezequiel Borgia¹, Maya Gerstein¹, Deborah M. Levy², Earl D. Silverman¹ and Linda T Hiraki³, ¹Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ²Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, ³The Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: Macrophage activation syndrome (MAS) is a life-threatening inflammatory complication of pediatric systemic lupus erythematosus (pSLE). There are few reports of the presentation, treatment and outcome of…

Abstracts tagged "SLE and pediatric rheumatology"

Frequency of the Systemic Lupus Collaborating Clinics- Damage Index Items in Three Registries of Childhood-Onset Systemic Lupus Erythematosus

Features, Treatment and Outcome of Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus